Extra hormone support after embryo transfer for low progesterone
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This trial tests whether giving extra progesterone injections after an embryo transfer can improve pregnancy outcomes for women who have low progesterone levels. It may help support the pregnancy in its early stages.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 37 years old.
- Your body mass index (BMI) is below 34.
- You have had a fresh embryo transfer as part of IVF, and your pregnancy test is positive.
- A blood test shows your progesterone level is below 17 ng/mL on the day of the pregnancy test.
- You are able to give yourself progesterone injections under the skin, or have someone who can help you do that.
- You are not using any other progesterone treatments or medications that boost progesterone, and you do not have any condition that prevents you from receiving these injections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how progesterone levels change in the early part of the luteal phase (after ovulation) when ovulation is triggered by an hCG injection in a natural cycle. It may help women undergoing routine ovulation induction understand how their body responds.
This Phase 3 study tests whether adding micronized progesterone during frozen embryo transfer cycles helps support embryo implantation and pregnancy. You may benefit if your care team is already preparing the uterus with hormone therapy for a blastocyst transfer.
This study tests how hormone levels (progesterone) change day to day in the lining of the uterus (endometrium) during an embryo transfer in a medicated cycle. The goal is to better time the transfer and improve success rates.
This trial tests whether taking progesterone for longer during an IVF pregnancy can help lower the risk of preterm birth (birth too early). It is for people who are pregnant from a fresh embryo transfer of a single embryo.
This Phase 1 study compares pregnancy outcomes, especially live birth, when using a natural-cycle frozen embryo transfer with an embryo that is genetically euploid (normal chromosome number) versus doing transfers without luteal (progesterone) phase support. It may help determine whether adding progesterone around ovulation improves the chance of a live birth.
This Phase 3 study tests whether taking an oral progesterone-like medicine (dydrogesterone) during the “luteal phase” after a natural-cycle frozen embryo transfer can improve support for implantation. It may help couples who are using their own embryos in a natural (hormone-sparing) cycle after thawing.
Hear when a new Pregnancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.